Roquefort Therapeutics plc (ROQAF PINK) stock market data APIs
$0.1308
0(0%)
as of July 16, 2026
Try our APIs with
free plan!
Roquefort Therapeutics plc Financial Data Overview
Price chart is built with
Anychart
Coiled Therapeutics plc, a clinical stage oncology company, develops precision oncology therapies. It develops AO-252, a TACC3 inhibitor that is in Phase I clinical trials; and STAT-6 siRNA program, which is in preclinical trials for treating immunology indications. The company is based in London, United Kingdom.
Prev. Close
0.1308
Open
0.1308
High
0.1308
Low
0.1308
52 wk Range
0.0021-0.2135
Market Cap
61 941 K
Shares Outstanding
426 M
Beta
-0.559
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roquefort Therapeutics plc data using free add-ons & libraries
Get Roquefort Therapeutics plc Fundamental Data
Roquefort Therapeutics plc Fundamental data includes:
- Net Revenue:
- EBITDA: -926 731
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Roquefort Therapeutics plc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roquefort Therapeutics plc News
New
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Virtual Investor Conferences Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the lea...
Life Sciences Virtual Investor Forum Agenda Announced for March 9th
Virtual Investor Conferences Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, th...
Get Roquefort Therapeutics plc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
